3Romano A,Viola M,Gaeta F,et al.Patch testing in non-immediate drug eruptions[J].Allergy Asthma Clin Immunol,2008,4(2):66-74.
4Corvec S, Tafin U F , Betrisey Bvet al. Activities of fosfomycin, tigecycline , colistin and gentamicin against extended-spectrum?-lactamase-producing Escherichia coli in a foreign-body infec?tion model[J]. Antimicrob Agents and Chemotherap,2013,57 (3): 1421-1427.
5Matsui Y, Kobayashi K, Masuda H, et al. Quantitative analysis of saponins in a tea-leaf extract and their antihypercholester?olemic Activity l]], Biosci Biotechnol Biochem , 2009, 73 (7): 1513-1519.
6Li Y,Du YM,Zou C. Effects of pH on antioxidant and antimi?crobial properties of tea saponins[J]. Euro Food Res Technol, 2009,228(6):1023-1028.
7Hao W N,Li H,Hu M Y,et al. Integrated control of citrus green and blue mold and sour rot by bacillus arnyloliquefa?ciens in combination with tea saponin[J]. Postharvest Bioi Technol, 2011,59(3) : 316-323.
8MeletiadisJ,Acques F G M,]ohan w.? al. Comparison of NCCLS and 3-( 4, 5-dimethyl-2-thiazyl)-2, 5-diphenyl-2H-tet?razolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simpli?fied method[J]. Clin Microbiol,2000,38(8) :2949-2954.
9Wang HW,Cheng HR,WangFQ,etal. An improved 3-(4, 5-dimethylthiazol-2-yl )-2, 5-diphenyl tetrazolium bromide (M'TT'i reduction assay for evaluating the viability of Esche?richia coli cells[J].J Microbiol Meth,2010,82(3) :30-333.
10Loreto S Ev Alves D,Mario Nvet al. In vitro[A60J suscepti?bility of pythium insidiosum to macrolides and tetracycline an?tibiotics[J]. Antimicrob Agent Chernother , 2011, 55 (7): 3588-3590.
